ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

Diagnosis-Treatment Cidac contract Gets Recompetition Okay

December 16, 1983

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

National Academy elects New Members

May 9, 1997